>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Minggu, 18 April 2010

Mandiri Sekuritas SMRA: Defensive and Progressive

SMRA booked strong 77.7% yoy increase in FY09 net income, thanks to a significant improvement in gross margin, that slid into the bottom line. We see greater prospects in 2010, as low mortgage rate trend will provide support for demand, especially for its Serpong and Bekasi projects that cover major contribution on marketing sales target this year. We maintain Buy on the stock, currently trading at 46.3% discount to our revised NAV10F

78%yoy earnings growth in 2009. SMRA reported a strong FY09 result, up by 77.7% yoy to Rp167bn. The highest net income to date was supported by strong gross margin, with COGS decreasing 21.6%, although revenue slipped by 5.5% yoy. The improved margin came as a shift in sales portfolio favored higher-margin lot sales.

Healthy marketing pick up seen in 2Q10. Marketing sales is targeted at sustainable growth this year to reach Rp1.6 tn (32.2% yoy), backed by the inclusion of the ready to launch Bekasi project (end of April10) that set to contribute up to 20% of total sales. Serpong and Kelapa Gading will provide the balance, with Serpong remains as the top contributor with 44%. As per Mar10, the company’s marketing sales indicated a 36%yoy jump to Rp321bn or about 20% of FY10F. Although running slightly below FY10F target, the chunk of demand is destined for 2Q10, which shall include the Bekasi numbers (launched end of Apr10)

Buy with TP upgraded. Bolstered by a sound mix of recurring and property income, we continue to be positive on SMRA. Our revised NAV10F shows a value of Rp1,130/share. Thus, the stock currently trades at a 46.3% discount to NAV10F. We are still with buy recommendation on the stock. Main risks are (a) unexpected rise in interest rates and (b) project delivery delays.

Tidak ada komentar:

Posting Komentar

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News